These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26553731)

  • 1. General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review.
    Hougaard A; Tfelt-Hansen P
    Cephalalgia; 2016 Sep; 36(10):960-9. PubMed ID: 26553731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A; Song D; Zhang L; Li C
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM; Schultz LL; Gilkey SJ
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
    Woolley JM; Bonafede MM; Maiese BA; Lenz RA
    Headache; 2017 Oct; 57(9):1399-1408. PubMed ID: 28842990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamins and Minerals for Migraine Prophylaxis: A Systematic Review and Meta-analysis.
    Okoli GN; Rabbani R; Kashani HH; Wierzbowski AK; Neilson C; Mansouri B; Zarychanski R; Abou-Setta AM
    Can J Neurol Sci; 2019 Mar; 46(2):224-233. PubMed ID: 30764890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo response in clinical randomized trials of analgesics in migraine.
    Bendtsen L; Mattsson P; Zwart JA; Lipton RB
    Cephalalgia; 2003 Sep; 23(7):487-90. PubMed ID: 12950372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.
    Deen M; Martinelli D; Pijpers J; Diener HC; Silberstein S; Ferrari MD; Ashina M; Tassorelli C; Yuan H
    Cephalalgia; 2019 Jul; 39(8):1058-1066. PubMed ID: 31042062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the current IHS guidelines for migraine drug trials being followed?
    Hougaard A; Tfelt-Hansen P
    J Headache Pain; 2010 Dec; 11(6):457-68. PubMed ID: 20931348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.
    Silberstein S; Tfelt-Hansen P; Dodick DW; Limmroth V; Lipton RB; Pascual J; Wang SJ;
    Cephalalgia; 2008 May; 28(5):484-95. PubMed ID: 18294250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment efficacy of galcanezumab for migraine: A meta-analysis of randomized controlled trials.
    Ren Z; Zhang H; Wang R; Yuan Q; Pan L; Chen C
    Clin Neurol Neurosurg; 2019 Nov; 186():105428. PubMed ID: 31581028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
    von Luckner A; Riederer F
    Headache; 2018 Feb; 58(2):199-209. PubMed ID: 29131326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
    Loder E; Goldstein R; Biondi D
    Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S; Marziniak M; Frese A; Gralow I
    Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal migraine.
    Napthali K; Koloski N; Talley NJ
    Cephalalgia; 2016 Sep; 36(10):980-6. PubMed ID: 26582952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010-2015 on migraine drug treatments.
    Tfelt-Hansen P; Lindqvist JK; Do TP
    Cephalalgia; 2018 Oct; 38(12):1885-1895. PubMed ID: 29448820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of children with migraine in the emergency department: a qualitative systematic review.
    Bailey B; McManus BC
    Pediatr Emerg Care; 2008 May; 24(5):321-30. PubMed ID: 18496120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials.
    Damen L; Bruijn J; Verhagen AP; Berger MY; Passchier J; Koes BW
    Cephalalgia; 2006 May; 26(5):497-505. PubMed ID: 16674757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.
    Meissner K; Fässler M; Rücker G; Kleijnen J; Hróbjartsson A; Schneider A; Antes G; Linde K
    JAMA Intern Med; 2013 Nov; 173(21):1941-51. PubMed ID: 24126676
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.